Mikaxyle 250 Injection contains Amikacin (250mg), a powerful aminoglycoside antibiotic known for its broad-spectrum activity against various gram-negative and select gram-positive bacteria. It is commonly used in treating severe and complicated infections resistant to other antibiotics. Amikacin works by interfering with bacterial protein synthesis, effectively stopping the growth and spread of bacteria, making it particularly effective in managing life-threatening infections.
Mikaxyle 250 Injection is widely employed in hospital and clinical settings to treat conditions like sepsis, complicated urinary tract infections, intra-abdominal infections, and infections of the respiratory tract, skin, and soft tissues. This formulation ensures rapid action, particularly in acute and critical infections.
This antibiotic is especially useful in combating infections caused by drug-resistant bacteria, including species such as Pseudomonas aeruginosa, Enterobacter, and Escherichia coli. Administered via intramuscular or intravenous routes, it ensures high bioavailability and efficacy in targeting bacterial infections.